These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 3893700)

  • 1. Evaluation of ciclopirox olamine cream for the treatment of tinea pedis: multicenter, double-blind comparative studies.
    Clin Ther; 1985; 7(4):409-17. PubMed ID: 3893700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of tinea versicolor with a new antifungal agent, ciclopirox olamine cream 1%.
    Clin Ther; 1985; 7(5):574-83. PubMed ID: 2865009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.
    Aly R; Maibach HI; Bagatell FK; Dittmar W; Hänel H; Falanga V; Leyden JJ; Roth HL; Stoughton RB; Willis I
    Clin Ther; 1989; 11(3):290-303. PubMed ID: 2663159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a new antifungal cream, ciclopirox olamine 1% in the treatment of cutaneous candidosis.
    Clin Ther; 1985; 8(1):41-8. PubMed ID: 2870809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre double-blind clinical trials of ciclopirox olamine cream 1% in the treatment of tinea corporis and tinea cruris.
    Bogaert H; Cordero C; Ollague W; Savin RC; Shalita AR; Zaias N
    J Int Med Res; 1986; 14(4):210-6. PubMed ID: 3530834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ciclopirox olamine 1% cream with ciclopirox 1%-hydrocortisone acetate 1% cream in the treatment of inflamed superficial mycoses.
    Lassus A; Nolting KS; Savopoulos C
    Clin Ther; 1988; 10(5):594-9. PubMed ID: 2856602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial.
    Gupta AK; Skinner AR; Cooper EA
    Int J Dermatol; 2005 Jul; 44(7):590-3. PubMed ID: 15985032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedis.
    Leenutaphong V; Niumpradit N; Tangwiwat S; Sritaveesuwan R; Muanprasat C
    J Med Assoc Thai; 1999 Oct; 82(10):1006-10. PubMed ID: 10561963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of 40% urea cream in the treatment of moccasin tinea pedis.
    Elewski BE; Haley HR; Robbins CM
    Cutis; 2004 May; 73(5):355-7. PubMed ID: 15186053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-finding comparative study of 2 weeks of luliconazole cream treatment for tinea pedis--comparison between three groups (1%, 0.5%, 0.1%) by a multi-center randomised double-blind study.
    Watanabe S; Takahashi H; Nishikawa T; Takiuchi I; Higashi N; Nishimoto K; Kagawa S; Yamaguchi H; Ogawa H
    Mycoses; 2007 Jan; 50(1):35-40. PubMed ID: 17302746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo.
    Shuster S; Meynadier J; Kerl H; Nolting S
    Arch Dermatol; 2005 Jan; 141(1):47-52. PubMed ID: 15655141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis on patients with tinea pedis: an explorative pilot study controlled with ketoconazole.
    Romero-Cerecero O; Rojas G; Navarro V; Herrera-Arellano A; Zamilpa-Alvarez A; Tortoriello J
    Planta Med; 2006 Nov; 72(14):1257-61. PubMed ID: 17051456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
    Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
    J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciclopirox gel in the treatment of patients with interdigital tinea pedis.
    Aly R; Fisher G; Katz I; Levine N; Lookingbill DP; Lowe N; Menter A; Morman M; Pariser DM; Roth HL; Savin RC; Shavin JS; Stewart D; Taylor JR; Tucker S; Wortzman M
    Int J Dermatol; 2003 Sep; 42 Suppl 1():29-35. PubMed ID: 14567368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
    Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naftifine cream 1% versus clotrimazole cream 1% in the treatment of tinea pedis. Naftifine Podiatric Study Group.
    J Am Podiatr Med Assoc; 1990 Jun; 80(6):314-8. PubMed ID: 2189989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of terbinafine and clotrimazole in treating tinea pedis.
    Evans EG; Dodman B; Williamson DM; Brown GJ; Bowen RG
    BMJ; 1993 Sep; 307(6905):645-7. PubMed ID: 8401048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of sertaconazole nitrate cream 2% for tinea pedis.
    Savin R; Jorizzo J
    Cutis; 2006 Oct; 78(4):268-74. PubMed ID: 17121064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study.
    Jarratt M; Jones T; Adelglass J; Bucko A; Pollak R; Roman-Miranda A; Olin JT; Swinyer L
    J Drugs Dermatol; 2014 Jul; 13(7):838-46. PubMed ID: 25007368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.